Demers Philippe, Miller D Craig, Mitchell R Scott, Kee Stephen T, Sze Daniel, Razavi Mahmood K, Dake Michael D
Department of Cardiovascular Surgery, Division of Cardiovascular and Interventional Radiology, Stanford University School of Medicine, Stanford, CA 94305-5247, USA.
J Thorac Cardiovasc Surg. 2004 Mar;127(3):664-73. doi: 10.1016/j.jtcvs.2003.10.047.
Five years after reporting our initial stent-graft repair of descending thoracic aortic aneurysms experience, we determined the 5- to 10-year results of stent-graft treatment and identified risk factors for adverse late outcomes.
Between 1992 and 1997, 103 patients (mean age 69 +/- 12 years) underwent repair using first-generation (custom-fabricated) stent grafts. Sixty-two patients (60%) were unsuitable candidates for conventional open surgical repair ("inoperable"). Follow-up was 100% complete (mean 4.5 +/- 2.5 years; maximum 10 years). Outcome variables included death and treatment failure (endoleak, aortic rupture, reintervention, and/or aortic-related or sudden death).
Overall actuarial survival was 82% +/- 4%, 49% +/- 5%, and 27% +/- 6% at 1, 5, and 8 years. Survival in open surgical candidates was 93% +/- 4% and 78% +/- 6% and at 1 and 5 years compared with 74% +/- 6% and 31% +/- 6% in those deemed inoperable (P <.001). Independent risk factors for death were older age (hazard ratio = 1.1; P =.008), previous stroke (hazard ratio = 2.8; P =.003), and being designated an inoperable candidate (hazard ratio = 1.9; P =.04). Actuarial freedom from aortic reintervention and treatment failure at 8 years was 70% +/- 6% and 39% +/- 8%, respectively. Earlier operative year (hazard ratio = 1.2; P =.07), larger distal landing zone diameter (hazard ratio = 1.1; P =.001), and transposition of the left subclavian artery (hazard ratio = 3.3; P =.008) were determinants of treatment failure.
Survival after aneurysm repair using crude, first-generation stent grafts was satisfactory in good operative candidates but bleak in the inoperable cohort, raising the question of whether asymptomatic patients should have even been treated. Late aortic complications were detected in many patients, reemphasizing the importance of serial imaging surveillance.
在报告我们最初对降主动脉瘤进行支架移植物修复的经验五年后,我们确定了支架移植物治疗5至10年的结果,并确定了晚期不良结局的危险因素。
1992年至1997年间,103例患者(平均年龄69±12岁)接受了第一代(定制)支架移植物修复。62例患者(60%)不适合进行传统的开放手术修复(“无法手术”)。随访率为100%(平均4.5±2.5年;最长10年)。结局变量包括死亡和治疗失败(内漏、主动脉破裂、再次干预和/或与主动脉相关的死亡或猝死)。
1年、5年和8年时的总体精算生存率分别为82%±4%、49%±5%和27%±6%。可进行开放手术的患者1年和5年时的生存率分别为93%±4%和78%±6%,而被认为无法手术的患者为74%±6%和31%±6%(P<.001)。死亡的独立危险因素为年龄较大(风险比=1.1;P=.008)、既往中风(风险比=2.8;P=.003)以及被判定为无法手术的患者(风险比=1.9;P=.04)。8年时主动脉再次干预和治疗失败的精算无事件生存率分别为70%±6%和39%±8%。手术年份较早(风险比=1.2;P=.07)、远端锚定区直径较大(风险比=1.1;P=.001)以及左锁骨下动脉移位(风险比=3.3;P=.008)是治疗失败的决定因素。
使用原始第一代支架移植物进行动脉瘤修复后,可进行良好手术的患者生存率令人满意,但无法手术的患者生存率很低,这就提出了无症状患者是否甚至应该接受治疗的问题。许多患者检测到晚期主动脉并发症,再次强调了系列影像学监测的重要性。